SimãoM. C. S. A.; GodoyJ. T.; OliveiraA. M.; BorjaB. M.; de AlmeidaF. S.; MendonçaL. P.; IsolaniL. F.; LopesA. G. Chloroquine and hydroxychloroquine: the risk of QT interval prolongation when using the recommended dose for the treatment of COVID-19. Electronic Journal Collection Health, v. 12, n. 10, p. e4694, 10 out. 2020.